Freddo James L 4
4 · ANADYS PHARMACEUTICALS INC · Filed Dec 7, 2009
Insider Transaction Report
Form 4
Freddo James L
SVP, Drug Development and CMO
Transactions
- Award
Stock Option (Right to Buy)
2009-12-03+73,500→ 73,500 totalExercise: $2.42From: 2010-12-03Exp: 2019-12-02→ Common Stock (73,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of grant with the remaining shares subject to the option vesting in equal installments over the next three years such that all shares subject to the option will be fully vested and exercisable as of December 3, 2013.